243 related articles for article (PubMed ID: 9834100)
1. The importance of TGF-beta in murine visceral leishmaniasis.
Wilson ME; Young BM; Davidson BL; Mente KA; McGowan SE
J Immunol; 1998 Dec; 161(11):6148-55. PubMed ID: 9834100
[TBL] [Abstract][Full Text] [Related]
2. The TGF-beta response to Leishmania chagasi in the absence of IL-12.
Wilson ME; Recker TJ; Rodriguez NE; Young BM; Burnell KK; Streit JA; Kline JN
Eur J Immunol; 2002 Dec; 32(12):3556-65. PubMed ID: 12516540
[TBL] [Abstract][Full Text] [Related]
3. Differential production of Th1- and Th2-derived cytokines does not determine the genetically controlled or vaccine-induced rate of cure in murine visceral leishmaniasis.
Kaye PM; Curry AJ; Blackwell JM
J Immunol; 1991 Apr; 146(8):2763-70. PubMed ID: 1901883
[TBL] [Abstract][Full Text] [Related]
4. BCG expressing LCR1 of Leishmania chagasi induces protective immunity in susceptible mice.
Streit JA; Recker TJ; Donelson JE; Wilson ME
Exp Parasitol; 2000 Jan; 94(1):33-41. PubMed ID: 10631078
[TBL] [Abstract][Full Text] [Related]
5. Local suppression of IFN-gamma in hepatic granulomas correlates with tissue-specific replication of Leishmania chagasi.
Wilson ME; Sandor M; Blum AM; Young BM; Metwali A; Elliott D; Lynch RG; Weinstock JV
J Immunol; 1996 Mar; 156(6):2231-9. PubMed ID: 8690913
[TBL] [Abstract][Full Text] [Related]
6. Complete protection against experimental visceral leishmaniasis with complete soluble antigen from attenuated Leishmania donovani promastigotes involves Th1-immunity and down-regulation of IL-10.
Bhaumik SK; Naskar K; De T
Eur J Immunol; 2009 Aug; 39(8):2146-60. PubMed ID: 19593771
[TBL] [Abstract][Full Text] [Related]
7. Long-lasting protection against canine visceral leishmaniasis using the LiESAp-MDP vaccine in endemic areas of France: double-blind randomised efficacy field trial.
Lemesre JL; Holzmuller P; Gonçalves RB; Bourdoiseau G; Hugnet C; Cavaleyra M; Papierok G
Vaccine; 2007 May; 25(21):4223-34. PubMed ID: 17395339
[TBL] [Abstract][Full Text] [Related]
8. Experimental visceral leishmaniasis: production of interleukin 2 and interferon-gamma, tissue immune reaction, and response to treatment with interleukin 2 and interferon-gamma.
Murray HW; Stern JJ; Welte K; Rubin BY; Carriero SM; Nathan CF
J Immunol; 1987 Apr; 138(7):2290-7. PubMed ID: 3104456
[TBL] [Abstract][Full Text] [Related]
9. [TH1 response in the experimental infection with Trypanosoma cruzi].
Cardoni RL; Antúnez MI; Abrami AA
Medicina (B Aires); 1999; 59 Suppl 2():84-90. PubMed ID: 10668248
[TBL] [Abstract][Full Text] [Related]
10. Hepatic cellular immune responses in mice with "cure" and "non-cure" phenotype to Leishmania infantum infection: importance of CD8+ T cells and TGF-beta production.
Gomes-Pereira S; Rodrigues OR; Rolão N; Almeida PD; Santos-Gomes GM
FEMS Immunol Med Microbiol; 2004 May; 41(1):59-68. PubMed ID: 15094168
[TBL] [Abstract][Full Text] [Related]
11. Leishmania infantum: soluble proteins released by the parasite exert differential effects on host immune response.
Rosa R; Rodrigues OR; Marques C; Santos-Gomes GM
Exp Parasitol; 2005 Feb; 109(2):106-14. PubMed ID: 15687017
[TBL] [Abstract][Full Text] [Related]
12. Vaccination with the Leishmania infantum acidic ribosomal P0 protein plus CpG oligodeoxynucleotides induces protection against cutaneous leishmaniasis in C57BL/6 mice but does not prevent progressive disease in BALB/c mice.
Iborra S; Carrión J; Anderson C; Alonso C; Sacks D; Soto M
Infect Immun; 2005 Sep; 73(9):5842-52. PubMed ID: 16113303
[TBL] [Abstract][Full Text] [Related]
13. Alterations in cytokine production following intraocular injection of soluble protein antigen: impairment in IFN-gamma and induction of TGF-beta and IL-4 production.
Kosiewicz MM; Alard P; Streilein JW
J Immunol; 1998 Nov; 161(10):5382-90. PubMed ID: 9820512
[TBL] [Abstract][Full Text] [Related]
14. Cellular vaccination with bone marrow-derived dendritic cells pulsed with a peptide of Leishmania infantum KMP-11 and CpG oligonucleotides induces protection in a murine model of visceral leishmaniasis.
Agallou M; Margaroni M; Karagouni E
Vaccine; 2011 Jul; 29(31):5053-64. PubMed ID: 21569815
[TBL] [Abstract][Full Text] [Related]
15. Localization and regulation of IFN-gamma production within the granulomas of murine schistosomiasis in IL-4-deficient and control mice.
Rakasz E; Blum AM; Metwali A; Elliott DE; Li J; Ballas ZK; Qadir K; Lynch R; Weinstock JV
J Immunol; 1998 May; 160(10):4994-9. PubMed ID: 9590248
[TBL] [Abstract][Full Text] [Related]
16. [Interpretation of laboratory data during cryptic leishmaniasis in dog].
Gravino AE
Parassitologia; 2004 Jun; 46(1-2):227-9. PubMed ID: 15305723
[TBL] [Abstract][Full Text] [Related]
17. A single intramuscular injection with an adenovirus-expressing IL-12 protects BALB/c mice against Leishmania major infection, while treatment with an IL-4-expressing vector increases disease susceptibility in B10.D2 mice.
Gabaglia CR; Pedersen B; Hitt M; Burdin N; Sercarz EE; Graham FL; Gauldie J; Braciak TA
J Immunol; 1999 Jan; 162(2):753-60. PubMed ID: 9916695
[TBL] [Abstract][Full Text] [Related]
18. IL-10 and IL-12 are the main regulatory cytokines in visceral leishmaniasis.
Bacellar O; D'oliveira A; Jerônimo S; Carvalho EM
Cytokine; 2000 Aug; 12(8):1228-31. PubMed ID: 10930301
[TBL] [Abstract][Full Text] [Related]
19. Recombinant Leishmania tarentolae expressing the A2 virulence gene as a novel candidate vaccine against visceral leishmaniasis.
Mizbani A; Taheri T; Zahedifard F; Taslimi Y; Azizi H; Azadmanesh K; Papadopoulou B; Rafati S
Vaccine; 2009 Dec; 28(1):53-62. PubMed ID: 19818721
[TBL] [Abstract][Full Text] [Related]
20. Immunization with the cysteine proteinase Ldccys1 gene from Leishmania (Leishmania) chagasi and the recombinant Ldccys1 protein elicits protective immune responses in a murine model of visceral leishmaniasis.
Ferreira JH; Gentil LG; Dias SS; Fedeli CE; Katz S; Barbiéri CL
Vaccine; 2008 Jan; 26(5):677-85. PubMed ID: 18160187
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
